Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 2014

View Archived Issues

Development of adipocyte-specific lactate receptor inhibitor for the treatment of dyslipidemia

RaQualia Pharma reports data on novel ghrelin receptor agonist

Potentially heat-stable HBV oral vaccine candidate presented

Adjuvanted pertussis vaccine with enhanced protection and thermal stability

Novel homoisoflavonoid analogue for the inhibition of angiogenesis

GSK presents highlights of first quarter 2014

Antipsychotic efficacy of phosphodiesterase inhibition compared with dopamine receptor blockade

Selective lipopeptide nanoparticle-mediated gene silencing of hepatocytes in preclinical models

Novel therapeutic targeting an alternate angiogenic signal pathway

Pre-IBD Consortium formed to research on IBD prevention

Selexys and Cytovance form antibody manufacturing agreement

Double-blind trial finds (S)-(-)-OSU-6162 effective in treating alcohol dependence

Naurex reports topline phase IIb data for GLYX-13 and advances NRX-1074

reMYND's novel diabetes treatment prevents disease progression in mouse model

biOasis peptide vector delivers siRNA to brain

Erytech cleared to begin phase II study ERY-ASP in pancreatic cancer in France

Evotec and Eternygen to identify and develop novel metabolic disease therapy

Ablynx's ALX-0171 completes two further phase I studies

Apitope begins preclinical development for ATX-F8-117

Novel orexin receptor antagonists disclosed by Actelion Pharmaceuticals

Japanese researchers present new agents for cancer

Hoffmann-La Roche discloses novel mGlu5 receptor positive allosteric modulators

Janssen R&D Ireland designs new TLR7/TLR8 receptor agonists

New anticancer agents patented by Chinese scientists

Antiplatelet agent vorapaxar approved by FDA

TGen and George Mason University form genomics and proteomics alliance

Anoro Ellipta approved in E.U. for COPD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.